Benzonatate

DEA Class; Rx

Common Brand Names; Tessalon, Tessalon Perles, Zonatuss

  • Antitussives

Oral nonnarcotic antitussive agent; chemically related to the ester-type local anesthetics; effective in suppressing cough particularly in cases of chronic cough resistant to opiate agonists; off-label use includes topical application to the oropharynx to obliterate the gag reflex prior to intubation or endoscopy.

Indicated for the symptomatic treatment of cough.

For the treatment of intractable singultus (hiccups) unresponsive to standard therapies.
For topical anesthesia of the oropharyngeal region prior to awake endotracheal intubation or prior to endoscopy.

Hypersensitivity to benzonatate and related compounds (tetracaine-type topical anesthetics)

  • Hypersensitivity reaction; bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule or perle
  • Chest numbness
  • Chilly sensation
  • Confusion
  • Constipation
  • Dizziness
  • GI upset
  • Hallucinations
  • Headache
  • Nasal congestion
  • Nausea
  • Pruritus
  • Sedation
  • Skin eruptions

Keep out of reach of children

Severe hypersensitivity reactions (bronchospasm, cardiovascular collapse) reported with therapy (possibly related to sucking or chewing the capsule)

Deliberate or accidental overdose has resulted in death, particularly in children

Isolated cases of abnormal behavior (mental confusion and visual hallucinations) reported

Pregnancy category: C

Lactation: Excretion in milk unknown; use caution

Adults

600 mg/day PO.

Geriatric

600 mg/day PO.

Adolescents

600 mg/day PO.

Children

10 years and older: 600 mg/day PO.
9 years and younger: Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

Neonates

Safety and efficacy have not been established.

Benzonatate 

capsule

  • 100mg
  • 150mg
  • 200mg

About the Author

You may also like these

0